Vnitr Lek 2010, 56(Suppl 1):78-80

Treatment of thrombocytopaenia in gravidity

A. Hluší*, J. Procházková, V. Krčová, K. Indrák
Hemato-onkologická klinika Lékařské fakulty UP a FN Olomouc, přednosta prof. MUDr. Karel Indrák, DrSc.

Immune thrombocytopaenia (ITP) is an acquired, immune disease characterized by a decrease in blood platelet count. The most frequent cause of thrombocyte deficiency in gravidity is benign gestational thrombocytopaenia, ITP is relatively rare. An optimal management of a pregnant patient with ITP involves good interdisciplinary collaboration between a haematologist, gynaecologist, anaesthesiologist and neonatologist. Depending on thrombocyte count, rigorous haematological follow-up is required. Pharmacological treatment is indicated in only a small proportion of patients and mainly involves administration of corticosteroids and immunoglonulines. After delivery, it is always necessary to assess the newborn for any manifestation of neonatal alloimmune thrombocytopaenia.

Keywords: immune thrombocytopaenia; gravidity; treatment

Received: April 16, 2010; Published: February 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hluší A, Procházková J, Krčová V, Indrák K. Treatment of thrombocytopaenia in gravidity. Vnitr Lek. 2010;56(Supplementum 1):78-80.
Download citation

References

  1. Bussel JB, Druzin ML, Cines DB et al. Thrombocytopenia in pregnancy. Lancet 1991; 337: 251. Go to original source... Go to PubMed...
  2. Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood 2005; 106: 2244-2251. Go to original source... Go to PubMed...
  3. Fujimura K, Harada Y, Fujimoto T et al. Nationwide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates. Int J Hematol 2002; 75: 426-433. Go to original source... Go to PubMed...
  4. George JN, Woolf SH, Raskob GE et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88: 3-46. Go to original source...
  5. Gill KK, Kelton JG. Management of idiopathic thrombocytopenic purpura in pregnancy. Semin Hematol 2000; 37: 275-289. Go to original source...
  6. Christiaens GC, Nieuwenhuis HK, von dem Borne AE et al. Idiopathic thrombocytopenic purpura in pregnancy: a randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count. Br J Obstet Gynaecol 1990; 97: 893-898. Go to original source... Go to PubMed...
  7. Provan D, Stasi R, Newland AC et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood; 2010; 115: 168-186. Go to original source... Go to PubMed...
  8. Provan D, Newland A, Bolton-Maggs P et al. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003; 120: 574-596. Go to original source... Go to PubMed...
  9. Rolbin SH, Abbott D, Musclow E et al. Epidural anesthesia in pregnant patients with low platelet counts. Obstet Gynecol 1988; 71: 918-920. Go to PubMed...
  10. Samuels P, Bussel JB, Braitman LE et al. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. N Engl J Med 1990; 323: 229-235. Go to original source... Go to PubMed...
  11. Veneri D, Franchini M, Raffaelli R et al. Idiopathic thrombocytopenic purpura in pregnancy: Analysis of 43 consecutive cases followed at a single Italian institution. Ann Hematol 2006; 85: 552-554. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.